Three common antihistamine medications have been found in preliminary tests to inhibit infection of cells by the coronavirus that causes COVID-19, University of Florida Health researchers have found. Their findings, based on laboratory tests of cells and a detailed analysis of nearly a quarter-million California patients’ medical records, are published today in the journal Biochemical and Biophysical Research Communications. The data may support the launch of a randomized, controlled clinical trial to determine whether the specific antihistamines can treat or even prevent COVID-19 in humans, the researchers said. Earlier this year, Leah Reznikov, Ph.D., an assistant professor of physiological sciences...